Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules

Area of Science:

• Immunology
• Transplantation Immunology
• Hepatocyte Biology

Background:

• Liver transplantation immunosuppression may involve hepatocyte-secreted MHC class I antigens.
• Hepatocytes play a crucial role in immune regulation following liver transplantation.

Purpose of the Study:

• To investigate the differential effects of membrane-bound versus secreted MHC class I antigens from hepatocytes on T lymphocyte responses.
• To explore the potential of secreted MHC class I antigens in inducing immune tolerance or suppression.

Main Methods:

• Co-culture of naive Lewis splenocytes with autologous hepatocytes transfected to express membrane-bound or secreted allogeneic MHC class I antigen (RT1.Aa).
• Limiting dilution assays to quantify cytotoxic T lymphocyte precursors (CTLp) and helper T lymphocyte precursors (HTLp).
• Assessment of allograft survival following adoptive transfer of preconditioned splenocytes.

Main Results:

• Hepatocytes secreting RT1.Aa specifically inhibited CTLp, while membrane-bound RT1.Aa primed CTLp.
• The CTLp priming by membrane-bound Ag was blocked by prior exposure to secreted RT1.Aa-secreting hepatocytes.
• Helper T lymphocyte precursor frequency was unaffected by either form of MHC antigen.
• Splenocytes conditioned with secreted allo-MHC Ag promoted suppressor cell development, evidenced by prolonged heart allograft survival.

Conclusions:

• Secreted MHC class I antigens by hepatocytes can induce antigen-specific inhibition of CTL precursors, suggesting a role in immune suppression.
• Hepatocyte-expressed membrane-bound MHC class I antigens can prime CTL responses.
• The interplay between secreted and membrane-bound MHC class I antigens influences T cell activation and tolerance induction.
• Secreted MHC class I antigens may be a therapeutic target for promoting allograft tolerance in liver transplantation.